Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received February 19, 2009
- Accepted after revision March 19, 2009
- Published online October 8, 2009.
Article Versions
- Latest version (May 27, 2009 - 06:44).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © American Society of Neuroradiology
Author Information
- aFrom the Department of Radiology (K.J.C., R.D.M., F.R.M.), University of South Florida, Tampa, Fla
- bUniversity Diagnostic Institute (R.D.M., F.R.M,), Tampa, Fla
- cDepartments of Diagnostic Imaging and Interdisciplinary Oncology (R.D.M., F.R.M.)
- dEndocrinology (H.L.)
- eCutaneous Surgery (J.W.), Moffitt Cancer Center and Research Institute, Tampa, Fla.
- Please address correspondence to Ryan D. Murtagh, MD, MBA, University Diagnostic Institute, 3301 Alumni Dr, Tampa FL 33629; e-mail: rmurtagh13{at}gmail.com
Altmetrics
Cited By...
In this issue
Jump to section
Related Articles
Cited By...
- MRI Findings of Immune Checkpoint Inhibitor-Induced Hypophysitis: Possible Association with Fibrosis
- Adrenal Insufficiency Related to Anti-Programmed Death-1 Therapy
- Ipilimumab Therapy for Melanoma: A Mimic of Leptomeningeal Metastases
- Long-term follow-up of ipilimumab-induced hypophysitis, a common adverse event of the anti-CTLA-4 antibody in melanoma
- ENDOCRINE SIDE-EFFECTS OF ANTI-CANCER DRUGS: mAbs and pituitary dysfunction: clinical evidence and pathogenic hypotheses
- Neurological immune-related adverse events of ipilimumab
- Ipilimumab and Its Toxicities: A Multidisciplinary Approach
- MECHANISMS IN ENDOCRINOLOGY: Ipilimumab: a novel immunomodulating therapy causing autoimmune hypophysitis: a case report and review